NCT06333821: A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma
- State
- Not started
- Phase
- Phase 3
- People
- 460 planned
- Started
- 1 Apr 2024
- Primary completion
- 1 Apr 2030
- Arms
- placebo for Nimotuzumab+chemoradiotherapy
- Results
- None posted
- 27 Mar 2024: Trial registered